Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,905.00
-33.40 (-1.72%)
Nov 12, 2026, 3:29 PM IST
Ipca Laboratories Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 104,798 | 96,472 | 89,412 | 77,059 | 62,481 | 58,305 |
Revenue Growth | 11.98% | 7.90% | 16.03% | 23.33% | 7.16% | 7.56% |
Gross Profit Gross Profit Growth | 71,801 | 64,855 | 58,598 | 48,584 | 37,252 | 36,225 |
Operating Income Operating Income Growth | 19,849 | 16,251 | 13,551 | 9,327 | 7,034 | 10,591 |
Net Income Net Income Growth | 14,024 | 11,411 | 7,377 | 5,474 | 4,713 | 8,841 |
Earnings Per Share EPS Growth | 54.19 | 44.98 | 29.08 | 21.57 | 18.58 | 34.85 |
EPS Growth | 60.64% | 54.69% | 34.77% | 16.13% | -46.69% | -22.58% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 47,269 | 43,866 | 40,420 | 36,143 | 32,655 | 30,112 |
USA USA Growth | - | 21,398 | 19,107 | - | - | - |
Outside India (Excluding United Kingdom) Outside India (Excluding United Kingdom) Growth | - | 31,199 | 29,868 | - | - | - |
Total Total Growth | 104,790 | 96,463 | 89,396 | 77,050 | 62,443 | 58,298 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 11,109 | 11,956 | 11,051 | 8,524 | 21,761 | 13,602 |
Total Debt Total Debt Growth | 7,528 | 8,088 | 13,627 | 14,384 | 14,813 | 8,072 |
Net Cash (Debt) Net Cash Growth | 3,582 | 3,868 | -2,577 | -5,859 | 6,949 | 5,530 |
Net Cash Growth | - | - | - | - | 25.65% | 12.06% |
Net Cash Per Share Net Cash Per Share Growth | 13.84 | 15.25 | -10.16 | -23.09 | 27.39 | 21.80 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 9,352 | 11,420 | 13,213 | 9,447 | 8,058 | 8,561 |
Capital Expenditures CapEx Growth | -6,373 | -6,560 | -7,756 | -4,113 | -4,945 | -4,790 |
Free Cash Flow Free Cash Flow Growth | 2,979 | 4,860 | 5,458 | 5,334 | 3,113 | 3,771 |
Free Cash Flow Growth | -36.57% | -10.95% | 2.32% | 71.31% | -17.44% | -48.24% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 68.51% | 67.23% | 65.54% | 63.05% | 59.62% | 62.13% |
Operating Margin | 18.94% | 16.85% | 15.16% | 12.10% | 11.26% | 18.16% |
Pretax Margin | 18.76% | 16.22% | 12.63% | 10.85% | 11.72% | 19.12% |
Profit Margin | 13.38% | 11.83% | 8.25% | 7.10% | 7.54% | 15.16% |
FCF Margin | 2.84% | 5.04% | 6.10% | 6.92% | 4.98% | 6.47% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 6.000 | 6.000 | 4.000 | 4.000 | 4.000 | 4.000 |
Dividend Per Share Growth | 50.00% | 50.00% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.32% | 0.38% | 0.27% | 0.32% | 0.49% | 0.38% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 35.15 | 35.60 | 51.65 | 57.36 | 43.62 | 30.58 |
Forward PE | 29.04 | 30.94 | 34.66 | 35.94 | 25.68 | 24.65 |
P/FCF Ratio | 162.22 | 83.58 | 69.82 | 58.86 | 66.03 | 71.70 |
PS Ratio | 4.61 | 4.21 | 4.26 | 4.07 | 3.29 | 4.64 |